Chase Pharmaceuticals Corporation

Chase Pharmaceuticals Corporation secures $21 million in Series B round for improved Alzheimer drug clinical trials

Chase Pharmaceuticals Corporation raises $21 million in a Series B financing round led by New Rhein Healthcare Investors, LLC.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics